1yiz image
Deposition Date 2005-01-13
Release Date 2005-05-10
Last Version Date 2024-04-03
Entry Detail
PDB ID:
1YIZ
Keywords:
Title:
Aedes aegypti kynurenine aminotrasferase
Biological Source:
Source Organism:
Aedes aegypti (Taxon ID: 7159)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.55 Å
R-Value Work:
0.25
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:kynurenine aminotransferase; glutamine transaminase
Chain IDs:A, B
Chain Length:429
Number of Molecules:2
Biological Source:Aedes aegypti
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
LLP A LYS ?
Ligand Molecules
Primary Citation
Crystal structures of Aedes aegypti kynurenine aminotransferase.
FEBS J. 272 2198 2206 (2005)
PMID: 15853804 DOI: 10.1111/j.1742-4658.2005.04643.x

Abstact

Aedes aegypti kynurenine aminotransferase (AeKAT) catalyzes the irreversible transamination of kynurenine to kynurenic acid, the natural antagonist of NMDA and 7-nicotinic acetycholine receptors. Here, we report the crystal structure of AeKAT in its PMP and PLP forms at 1.90 and 1.55 A, respectively. The structure was solved by a combination of single-wavelength anomalous dispersion and molecular replacement approaches. The initial search model in the molecular replacement method was built with the result of single-wavelength anomalous dispersion data from the Br-AeKAT crystal in combination with homology modeling. The solved structure shows that the enzyme is a homodimer, and that the two subunits are stabilized by a number of hydrogen bonds, salts bridges, and hydrophobic interactions. Each subunit is divided into an N-terminal arm and small and large domains. Based on its folding, the enzyme belongs to the prototypical fold type, aminotransferase subgroup I. The three-dimensional structure shows a strictly conserved 'PLP-phosphate binding cup' featuring PLP-dependent enzymes. The interaction between Cys284 (A) and Cys284 (B) is unique in AeKAT, which might explain the cysteine effect of AeKAT activity. Further mutation experiments of this residue are needed to eventually understand the mechanism of the enzyme modulation by cysteine.

Legend

Protein

Chemical

Disease

Primary Citation of related structures